These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 11793443)

  • 1. Discordance of genetic alterations between primary head and neck tumors and corresponding metastases associated with mutational status of the TP53 gene.
    Tabor MP; van Houten VM; Kummer JA; Vosjan MJ; Vlasblom R; Snow GB; Leemans CR; Braakhuis BJ; Brakenhoff RH
    Genes Chromosomes Cancer; 2002 Feb; 33(2):168-77. PubMed ID: 11793443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus.
    Braakhuis BJ; Snijders PJ; Keune WJ; Meijer CJ; Ruijter-Schippers HJ; Leemans CR; Brakenhoff RH
    J Natl Cancer Inst; 2004 Jul; 96(13):998-1006. PubMed ID: 15240783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer.
    van Ginkel JH; de Leng WW; de Bree R; van Es RJ; Willems SM
    Oncotarget; 2016 Sep; 7(38):61575-61586. PubMed ID: 27528217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The origins of multiple squamous cell carcinomas in the aerodigestive tract.
    van Oijen MG; Leppers Vd Straat FG; Tilanus MG; Slootweg PJ
    Cancer; 2000 Feb; 88(4):884-93. PubMed ID: 10679659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple high-grade bronchial dysplasia and squamous cell carcinoma: concordant and discordant mutations.
    Boyle JO; Lonardo F; Chang JH; Klimstra D; Rusch V; Dmitrovsky E
    Clin Cancer Res; 2001 Feb; 7(2):259-66. PubMed ID: 11234877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential diagnosis of pulmonary carcinoma following head and neck cancer by genetic analysis.
    Geurts TW; van Velthuysen ML; Broekman F; van Huysduynen TH; van den Brekel MW; van Zandwijk N; van Tinteren H; Nederlof P; Balm AJ; Brakenhoff RH
    Clin Cancer Res; 2009 Feb; 15(3):980-5. PubMed ID: 19188169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential loss of heterozygosity at microsatellite motifs in preinvasive and invasive head and neck squamous carcinoma.
    el-Naggar AK; Hurr K; Batsakis JG; Luna MA; Goepfert H; Huff V
    Cancer Res; 1995 Jun; 55(12):2656-9. PubMed ID: 7780981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allelotype of squamous cell carcinoma of the head and neck: fractional allele loss correlates with survival.
    Field JK; Kiaris H; Risk JM; Tsiriyotis C; Adamson R; Zoumpourlis V; Rowley H; Taylor K; Whittaker J; Howard P
    Br J Cancer; 1995 Nov; 72(5):1180-8. PubMed ID: 7577465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions.
    Ahomadegbe JC; Barrois M; Fogel S; Le Bihan ML; Douc-Rasy S; Duvillard P; Armand JP; Riou G
    Oncogene; 1995 Mar; 10(6):1217-27. PubMed ID: 7700647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal origin of lymph node metastases in bladder carcinoma.
    Jones TD; Carr MD; Eble JN; Wang M; Lopez-Beltran A; Cheng L
    Cancer; 2005 Nov; 104(9):1901-10. PubMed ID: 16196038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 tumor suppressor gene as a clonal marker in head and neck squamous cell carcinoma: p53 mutations in primary tumor and matched lymph node metastases.
    Tjebbes GW; Leppers vd Straat FG; Tilanus MG; Hordijk GJ; Slootweg PJ
    Oral Oncol; 1999 Jul; 35(4):384-9. PubMed ID: 10645403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma.
    Leong PP; Rezai B; Koch WM; Reed A; Eisele D; Lee DJ; Sidransky D; Jen J; Westra WH
    J Natl Cancer Inst; 1998 Jul; 90(13):972-7. PubMed ID: 9665144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent deletion of ING2 locus at 4q35.1 associates with advanced tumor stage in head and neck squamous cell carcinoma.
    Borkosky SS; Gunduz M; Nagatsuka H; Beder LB; Gunduz E; Ali MA; Rodriguez AP; Cilek MZ; Tominaga S; Yamanaka N; Shimizu K; Nagai N
    J Cancer Res Clin Oncol; 2009 May; 135(5):703-13. PubMed ID: 18998165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and clinicopathologic comparisons of head and neck squamous carcinoma variants: common and distinctive features of biological significance.
    Choi HR; Roberts DB; Johnigan RH; Sturgis EM; Rosenthal DI; Weber RS; Luna MA; Batsakis JG; El-Naggar AK
    Am J Surg Pathol; 2004 Oct; 28(10):1299-310. PubMed ID: 15371945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications.
    Tabor MP; Brakenhoff RH; van Houten VM; Kummer JA; Snel MH; Snijders PJ; Snow GB; Leemans CR; Braakhuis BJ
    Clin Cancer Res; 2001 Jun; 7(6):1523-32. PubMed ID: 11410486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of chromosome arm 18q with tumor progression in head and neck squamous cancer.
    Takebayashi S; Hickson A; Ogawa T; Jung KY; Mineta H; Ueda Y; Grénman R; Fisher SG; Carey TE
    Genes Chromosomes Cancer; 2004 Oct; 41(2):145-54. PubMed ID: 15287027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that loss of chromosome 18q is associated with tumor progression.
    Frank CJ; McClatchey KD; Devaney KO; Carey TE
    Cancer Res; 1997 Mar; 57(5):824-7. PubMed ID: 9041179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refined characterization of head and neck squamous cell carcinomas expressing a seemingly wild-type p53 protein.
    Leng K; Schlien S; Bosch FX
    J Oral Pathol Med; 2006 Jan; 35(1):19-24. PubMed ID: 16393249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratumoral genetic heterogeneity in primary head and neck squamous carcinoma using microsatellite markers.
    el-Naggar AK; Hurr K; Luna MA; Goepfert H; Hong WK; Batsakis JG
    Diagn Mol Pathol; 1997 Dec; 6(6):305-8. PubMed ID: 9559289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TP53 alterations as a potential diagnostic marker in superficial bladder carcinoma and in patients serum, plasma and urine samples.
    Dahse R; Utting M; Werner W; Schimmel B; Claussen U; Junker K
    Int J Oncol; 2002 Jan; 20(1):107-15. PubMed ID: 11743649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.